.png)
Agenzia Italiana del Farmaco
Nota 98
Farmaci a carico SSN inclusi nella Nota 98:
- aflibercept
- bevacizumab (L. 648/96)
- brolucizumab
- faricimab
- ranibizumab
Agenzia Italiana del Farmaco
Aifa toggle bar Search
-
The Agency
- The Agency
- Mission and values
- Organisation
- Scientific and Economic Committee for Medicines
- Support and Coordination Secretariats and Advisory Committees
- International Collaborations
- EU Projects
- Legislation
- Forms
- Competition notices
- Resolutions
- Tenders and contracts
- Quality assurance
- Guarantee Committee
- Atti di notifica
- AIFA Incontra
- Contacts
- Certified email
-
COVID-19
- COVID-19
- Communications about COVID-19
- COVID-19 Vaccines
- Medicines usable for treatment of COVID-19 disease
- Use of monoclonal antibodies for COVID-19
- Use of antivirals for COVID-19
- Monitoring of medicinal products used during the COVID-19 epidemic
- Clinical Trials - COVID-19
- Compassionate Use Programs - COVID-19
-
Access to medicinal products
- Access to medicinal products
- Early access and off-label use
- Authorisation of medicinal products
- Medicine shortages
- Antibiotic medicinal products
- Biological medicinal products
- Vaccines
- Blood derivatives
- Generic medicinal products
- Biosimilar medicinal products
- Orphan medicinal products
- Advanced therapies
- Homeopathic medicinal products
- Allergens
- Medicinali di origine vegetale
- Ancillary medicinal substances incorporated in medical devices
-
Safety of medicinal products
- Safety of medicinal products
- Pharmacovigilance
- National Pharmacovigilance Network
- Adverse Reactions to medicinal products
- Persons in charge of Pharmacovigilance
- European Eudravigilance System
- Accesso alle segnalazioni - ADRreports
- Regional pharmacovigilance funds
- Segnali di sicurezza
- Risk management measures
- Medicinal products subject to additional monitoring
- Quality and Inspections
-
Research and Clinical trials
- Research and Clinical trials
- Clinical trials concerning medicinal products
- EU Regulation on Clinical trials
- National Observatory on Clinical Trials
- Registro Studi Osservazionali
- Comitati Etici Nazionali (CEN)
- Ethics Committees Coordination Centre
- Independent clinical research
- Mappa dei centri di Sperimentazione Clinica
- Pricing and reimbursement
- Consumption and pharmaceutical expenditure
- Innovation and planning
-
Information and communication
- Information and communication
- FarmaciLine
- Medical and scientific information
- FAQ
- Publications
- Communication campaigns
- Eventi AIFA
- Scientific Seminars
- Press releases
- Mobile APP AIFA
- APP Firstline AIFA - Antibiotici
- ABC della Ricerca Clinica
- Presentations and speeches
- Public consultations
- Documents shared with scientific communities
- Calendario eventi
- Archivio
- AIFA data
- Companies Section
-
Open governance
- Open governance
- Disposizioni Generali
- Organizzazione
- Consulenti e collaboratori
- Personale
- Bandi di Concorso
- Performance
- Enti controllati
- Attività e procedimenti
- Provvedimenti
- Bandi di gara e contratti
- Sovvenzioni, contributi, sussidi, vantaggi economici
- Bilanci
- Beni immobili e gestione patrimonio
- Controlli e rilievi sull'Amministrazione
- Servizi Erogati
- Pagamenti dell'Amministrazione
- Opere pubbliche
- Pianificazione e governo del territorio
- Informazioni ambientali
- Interventi straordinari di emergenza
- Altri Contenuti
Agenzia Italiana del Farmaco
Cookie Bar
Footer
Contacts
Via del Tritone, 181 00187 Roma
VAT number: 08703841000
Tax code: 97345810580
IPA AIFA code: aifa_rm
IPA UCB code: UFE1TR